Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yeo, Seung-Gu | - |
dc.contributor.author | Kim, Min-Jeong | - |
dc.contributor.author | Kim, Dae Yong | - |
dc.contributor.author | Chang, Hee Jin | - |
dc.contributor.author | Kim, Min Ju | - |
dc.contributor.author | Baek, Ji Yeon | - |
dc.contributor.author | Kim, Sun Young | - |
dc.contributor.author | Kim, Tae Hyun | - |
dc.contributor.author | Park, Ji Won | - |
dc.contributor.author | Oh, Jae Hwan | - |
dc.date.accessioned | 2021-08-12T01:16:55Z | - |
dc.date.available | 2021-08-12T01:16:55Z | - |
dc.date.issued | 2013-05-06 | - |
dc.identifier.issn | 1748-717X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13691 | - |
dc.description.abstract | Background: We investigated patterns of failure in patients with locally advanced rectal cancer (LARC) according to chemoradiotherapy (CRT) timing: pre-operative versus post-operative. Also, patterns of failure, particularly distant metastasis (DM), were analyzed according to tumor location within the rectum. Methods: In total, 872 patients with LARC who had undergone concurrent CRT and radical surgery between 2001 and 2007 were analyzed retrospectively. Concurrent CRT was administered pre-operatively (cT3-4) or post-operatively (pT3-4 or pN+) in 550 (63.1%) and 322 (36.9%) patients, respectively. Median follow-up period was 86 (range, 12-133) months for 673 living patients. Local recurrence (LR) was defined as any disease recurrence within the pelvis, and any failure outside the pelvis was classified as a DM. Only the first site of recurrence was scored. Results: In total, 226 (25.9%) patients developed disease recurrence. In the pre-operative CRT group, the incidences of isolated LR, combined LR and DM, and isolated DM were 17, 21, and 89 patients, respectively. In the postoperative CRT group, these incidences were 8, 15, and 76 patients, respectively. LR within 2 years constituted 44.7% and 60.9% of all LRs in the pre-operative and post-operative CRT groups, respectively. Late (> 5 years) LR comprised 13.2% and 4.3% of all LRs in the pre-operative and post-operative CRT groups, respectively. The lung was the most common DM site (108/249, 43.4%). Lung or para-aortic lymph node metastasis developed more commonly from low-to-mid rectal tumors while liver metastasis developed more commonly from upper rectal tumors. Lung metastasis occurred later than liver metastasis (n = 54; 22.6 +/- 15.6 vs. 17.4 +/- 12.1 months; P = 0.035). Conclusions: This study showed that LARC patients receiving pre-operative CRT tended to develop late LR more often than those receiving post-operative CRT. Further extended follow-up than is conventional may be necessary in LARC patients who are managed with optimized multimodal treatments, and the follow-up strategy may need to be individualized according to tumor location within the rectum. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | BioMed Central | - |
dc.title | Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1186/1748-717X-8-114 | - |
dc.identifier.scopusid | 2-s2.0-84877018061 | - |
dc.identifier.wosid | 000318969400001 | - |
dc.identifier.bibliographicCitation | Radiation Oncology, v.8 | - |
dc.citation.title | Radiation Oncology | - |
dc.citation.volume | 8 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | RADIOTHERAPY | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | EXTRAPERITONEAL | - |
dc.subject.keywordPlus | RESECTION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | TIME | - |
dc.subject.keywordAuthor | Rectal cancer | - |
dc.subject.keywordAuthor | Pattern of failure | - |
dc.subject.keywordAuthor | Preoperative | - |
dc.subject.keywordAuthor | Postoperative | - |
dc.subject.keywordAuthor | Chemoradiotherapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.